Your browser doesn't support javascript.
loading
Prevalence of Amyloidosis in Korea.
Seo, Su Ra; Jang, Shin Yi; Lee, Ga Yeon; Choi, Bareun; Chun, Heeran; Cho, Eun Jeong; Cho, Sung-Il.
Afiliación
  • Seo SR; Graduate School of Public Health, Seoul National University, Seoul, 08826, Republic of Korea.
  • Jang SY; The National Health Insurance Service, Wonju, 25234, Republic of Korea.
  • Lee GY; Division of Cardiology, Department of Medicine, Imaging Center, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Republic of Korea. bautai@hanmail.net.
  • Choi B; Division of Cardiology, Department of Medicine, Imaging Center, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Republic of Korea.
  • Chun H; Namyangju Poongyang Public Health Center, Namyangju, 12066, Republic of Korea.
  • Cho EJ; Department of Health Administration, Jungwon University, Goesan, 28024, Republic of Korea.
  • Cho SI; Division of Cardiology, Department of Internal Medicine, Cardiology Clinic, National Cancer Center, Goyang, 10408, Republic of Korea.
Orphanet J Rare Dis ; 12(1): 152, 2017 09 06.
Article en En | MEDLINE | ID: mdl-28877709
BACKGROUND: The aim of this study was to assess in amyloidosis prevalence in Korea between 2006 and 2015. METHODS: Primary diagnoses related to amyloidosis, regardless of subtype, were collected from the Korean National Health Insurance Service from 2006 through 2015. RESULTS: Overall, the age-standardized prevalence of amyloidosis was 0.93 (95% confidence interval (CI) 0.81, 1.04) persons per 100,000 persons in 2006 and 1.91 (95% CI 1.78, 2.05) persons per 100,000 persons in 2015. This included an increase from 0.43 (95% CI 0.35, 0.51) to 1.04 (95% CI 0.94, 1.14) persons per 100,000 persons in men and from 0.49 (95% CI 0.40, 0.57) to 0.87 (95% CI 0.77, 0.96) persons per 100,000 persons in women. In particular, the age-standardized prevalence of amyloidosis showed a greater increase in patients aged 65 years or older and in patients aged 45-64 years than in patients aged 20-44 years, for both men and women. CONCLUSIONS: The overall age-standardized prevalence of amyloidosis was approximately 2 persons per 100,000 persons in 2015. The overall age-standardized prevalence of amyloidosis increased between 2006 and 2015, especially in individuals aged 45-64 and older than 65 years.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Amiloidosis Tipo de estudio: Etiology_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Orphanet J Rare Dis Asunto de la revista: MEDICINA Año: 2017 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Amiloidosis Tipo de estudio: Etiology_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Orphanet J Rare Dis Asunto de la revista: MEDICINA Año: 2017 Tipo del documento: Article Pais de publicación: Reino Unido